Enorama Pharma AB (publ) (STO:ERMA)

Market Cap	38.04M -70.3%
Revenue (ttm)	2.76M -82.5%
Net Income	-75.14M
EPS	n/a
Shares Out	74.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,798
Average Volume	105,281
Open	0.5500
Previous Close	0.5100
Day's Range	0.4520 - 0.5500
52-Week Range	0.2110 - 3.5800
Beta	1.37
RSI	42.58
Earnings Date	May 21, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 5
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ERMA

Financial Performance

In 2025, Enorama Pharma AB's revenue was 2.76 million, a decrease of -82.53% compared to the previous year's 15.77 million. Losses were -75.14 million, 71.5% more than in 2024.